share_log

Piper Sandler Initiates Coverage On Agios Pharmaceuticals With Overweight Rating, Announces Price Target of $41

Piper Sandler Initiates Coverage On Agios Pharmaceuticals With Overweight Rating, Announces Price Target of $41

派珀·桑德勒以超重評級啟動 Agios 藥品的覆蓋範圍,宣布目標價格為 41 美元
Benzinga Real-time News ·  2023/02/03 05:03

Piper Sandler analyst Christopher Raymond initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight rating and announces Price Target of $41.

Piper Sandler分析師Christopher Raymond對Agios PharmPharmticals(納斯達克:AGIO)發起增持評級,並宣佈目標價為41美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論